
dMed: A global Clinical Contract Research Organization providing comprehensive industry solutions to pharma and medical device companies.
Founded in [founding year], dMed is a global Clinical Contract Research Organization (CRO) dedicated to providing comprehensive industry solutions to pharmaceutical and medical device companies. With a mission to advance clinical research through personalized partnerships, dMed offers services including consulting, regulatory affairs and strategy, early clinical development, clinical science and medical affairs, clinical operations, biostatistics and programming, data management, drug safety and pharmacovigilance, quality assurance, and information solutions.
The company operates from major cities such as Shanghai, Beijing, Wuhan, New York, and Washington.nndMed has attracted notable investors and industry experts, contributing to its rapid growth and reputation in the clinical research field. Key achievements include successful collaborations with leading pharma and medical device companies, facilitating numerous clinical trials and regulatory approvals. The organization's impact is marked by its ability to streamline clinical research processes, enhance data integrity, and ensure compliance with global regulatory standards, ultimately accelerating the development of new therapies and medical devices.
Companies similar to Dmed include Tigermed, Medpace, MedChem Partners and KreaMedica.
Dmed was founded in 2016.
Dmed's headquarters is located in Batesville, MS, US.
Dmed's most recent funding round was for $50M (USD) in July 2021.
As of Jul 10, 2021, Dmed has disclosed funding of $214M (USD). Undisclosed round amounts are excluded.
Dmed has 20 employees as of Feb 4, 2024.
kreamedica.com